ZNF8 activators are a category of biochemical compounds designed to increase the functional activity of the Zinc Finger Protein 8 (ZNF8). ZNF8 is part of the zinc finger protein family, which is characterized by the presence of zinc finger motifs-folding structures that incorporate zinc ions to stabilize their configuration. These proteins typically function as transcription factors, binding to DNA and influencing the transcription of genes. The specific zinc finger motifs in ZNF8 allow it to interact with particular DNA sequences, thereby regulating the expression of certain genes. Activators that target ZNF8 are engineered to enhance this DNA-binding activity, which in turn could affect the expression levels of genes under ZNF8's regulatory control. The design and development of ZNF8 activators require a deep understanding of the protein's DNA-binding domain, its three-dimensional structure, and the precise mechanism by which it interacts with DNA and possibly other proteins involved in transcriptional regulation.
The discovery process for ZNF8 activators typically involves the use of high-throughput screening to identify molecules that can modulate ZNF8 activity. These molecules are then put through a series of biochemical assays to confirm their ability to enhance the function of ZNF8. The specificity of these activators is paramount to ensure that they do not interact with or activate other zinc finger proteins or transcription factors within the cell, as such off-target effects could disrupt the delicate balance of gene expression. Once compounds with the desired specificity are identified, they undergo an optimization process involving the modification of their chemical structures to improve their potency, selectivity, and overall ability to interact with ZNF8. This optimization is informed by detailed structural studies of ZNF8, often employing techniques such as X-ray crystallography or NMR spectroscopy to obtain high-resolution images of the protein in complex with the activator. Additionally, computational modeling techniques are used to simulate and predict how changes to the chemical structure of the activators might influence their interaction with ZNF8. The iterative process of synthesis, testing, and redesign aims to create refined compounds that can specifically and effectively modulate the activity of ZNF8, contributing to the basic understanding of ZNF8's role in gene expression and its interaction networks within the cell.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
As a DNA methyltransferase inhibitor, 5-azacytidine may result in hypomethylation of DNA and potentially lead to the upregulation of genes, including ZNF8. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits protein synthesis, which can lead to stress responses that might upregulate DNA repair genes, possibly impacting ZNF8 expression. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
An anthracycline antibiotic that induces DNA damage, doxorubicin might stimulate the DNA damage response and potentially enhance ZNF8 expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
As a topoisomerase inhibitor that induces DNA damage, camptothecin could activate DNA repair pathways, which may include upregulation of ZNF8. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide causes DNA strand breaks through inhibition of topoisomerase II, which might enhance the expression of DNA repair proteins like ZNF8. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, an isoflavone, has been shown to modulate several cellular signaling pathways and might influence the transcription of genes like ZNF8. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
As an activator of sirtuins and modulator of several signaling pathways, resveratrol might impact the expression of various genes, potentially including ZNF8. | ||||||
Arsenic(III) oxide | 1327-53-3 | sc-210837 sc-210837A | 250 g 1 kg | $89.00 $228.00 | ||
Arsenic trioxide can lead to oxidative stress and affect signal transduction, potentially altering the expression of stress response genes like ZNF8. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C, which can result in transcriptional changes in various genes, potentially including ZNF8. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
A synthetic glucocorticoid, dexamethasone, can regulate gene expression through the glucocorticoid receptor, possibly affecting ZNF8 expression. | ||||||